• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

链接到国家死亡索引如何影响沙特阿拉伯女性宫颈癌基于人群的净生存估计?

How does Linkage to the National Death Index Affect Population-Based Net Survival Estimates for Women with Cervical Cancer in Saudi Arabia?

机构信息

Department of Family and Community Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.

Cancer Survival Group, Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

出版信息

Gulf J Oncolog. 2023 Jan;1(41):17-22.

PMID:36804155
Abstract

BACKGROUND

Population-based cancer survival is a key metric for the assessment of cancer control strategies. Accurate estimation of cancer survival requires complete follow-up data for all patients.

AIM

To explore the impact of linking national cancer registry data to the national death index on net survival estimates for women diagnosed with cervical cancer in Saudi Arabia during 2005-2016.

METHODS

We acquired data on 1,250 Saudi women diagnosed with invasive cervical cancer during the 12- year period 2005-2016 from the Saudi Cancer Registry. These included the woman's last known vital status and the date of last known vital status, but this was restricted to information from clinical records and death certificates that mention cancer as a cause of death ("registry follow-up"). We submitted available national ID numbers to the National Information Center (NIC) of the Ministry of Interior, to ascertain the date of death, from any cause of death, for women who had died up until 31 December 2018 ("NIC follow-up"). We estimated age-standardised 5-year net survival using the Pohar-Perme estimator under five different scenarios using the two sources of follow-up, and censoring at the date of last contact with the registry versus extending survival until the closing date if no information on death was obtained.

RESULTS

1,219 women were eligible for survival analysis. Five-year net survival was lowest when using NIC followup only (56.8%; 95%CI 53.5 - 60.1%), and highest when registry follow-up only was used and survival time was extended until closure date for those with no information on death (81.8%; 95%CI 79.6 - 84%).

CONCLUSION

Reliance solely on information from deaths certified as due to cancer and clinical records leads to a high proportion of missing deaths in the national cancer registry. This is probably due to low quality of certification of the cause of death in Saudi Arabia. Linkage of the national cancer registry to the national death index at the NIC identifies virtually all deaths, providing more reliable survival estimates, and it eliminates the ambiguity in determining the underlying cause of death. Therefore, this should become the standard approach to estimating cancer survival in Saudi Arabia.

摘要

背景

基于人群的癌症生存是评估癌症控制策略的关键指标。准确估计癌症生存需要对所有患者进行完整的随访数据。

目的

探讨将国家癌症登记处的数据与国家死亡索引相链接,对 2005 年至 2016 年期间在沙特阿拉伯诊断为宫颈癌的女性的净生存估计值的影响。

方法

我们从沙特癌症登记处获取了在 12 年期间(2005-2016 年)被诊断患有浸润性宫颈癌的 1250 名沙特女性的数据。这些数据包括女性的最后已知生命状态和最后已知生命状态的日期,但仅限于临床记录和提及癌症作为死因的死亡证明中的信息(“登记处随访”)。我们向内政部国家信息中心(NIC)提交了可用的国家身份证号码,以确定截至 2018 年 12 月 31 日因任何原因死亡的女性的死亡日期(“NIC 随访”)。我们使用 Pohar-Perme 估计器,根据两种随访来源,在五个不同的情况下估计年龄标准化的 5 年净生存率,并在与登记处最后一次联系的日期截止,或在没有获得死亡信息的情况下将生存时间延长至截止日期。

结果

1219 名女性有资格进行生存分析。仅使用 NIC 随访时,5 年净生存率最低(56.8%;95%CI 53.5-60.1%),而仅使用登记处随访时,并且对于没有死亡信息的患者,将生存时间延长至截止日期时,生存率最高(81.8%;95%CI 79.6-84%)。

结论

仅依赖于经认证为癌症死亡和临床记录的信息,会导致国家癌症登记处大量缺失死亡信息。这可能是由于沙特阿拉伯死亡原因认证质量低所致。国家癌症登记处与 NIC 国家死亡索引的链接几乎可以识别所有死亡情况,提供更可靠的生存估计,并消除了确定根本死因的歧义。因此,这应该成为在沙特阿拉伯估计癌症生存的标准方法。

相似文献

1
How does Linkage to the National Death Index Affect Population-Based Net Survival Estimates for Women with Cervical Cancer in Saudi Arabia?链接到国家死亡索引如何影响沙特阿拉伯女性宫颈癌基于人群的净生存估计?
Gulf J Oncolog. 2023 Jan;1(41):17-22.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries.非洲、中美洲和南美洲以及亚洲的癌症生存率(SURVCAN-3):一项基于32个国家人口的基准研究。
Lancet Oncol. 2023 Jan;24(1):22-32. doi: 10.1016/S1470-2045(22)00704-5.
4
Colorectal cancer in Saudi Arabia: incidence, survival, demographics and implications for national policies.沙特阿拉伯的结直肠癌:发病率、生存率、人口统计学及对国家政策的影响。
Ann Saudi Med. 2015 May-Jun;35(3):196-202. doi: 10.5144/0256-4947.2015.196.
5
Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods.癌症登记数据的净生存:新无偏 Pohar-Perme 估计器的使用和经典方法的偏差幅度。
Int J Cancer. 2013 May 15;132(10):2359-69. doi: 10.1002/ijc.27830. Epub 2012 Oct 3.
6
A Novel Approach to Obtain Follow-up Data on the Vital Status of Registered Cancer Patients: The Kuwait Cancer Registry Experience.一种获取已登记癌症患者生命状态随访数据的新方法:科威特癌症登记处的经验。
Gulf J Oncolog. 2019 Jan;1(29):31-38.
7
The impact of National Death Index linkages on population-based cancer survival rates in the United States.国家死亡索引链接对美国基于人群的癌症生存率的影响。
Cancer Epidemiol. 2013 Feb;37(1):20-8. doi: 10.1016/j.canep.2012.08.007. Epub 2012 Sep 7.
8
Primary gastrointestinal cancers in the Western Region of Saudi Arabia. Is the pattern changing?沙特阿拉伯西部地区的原发性胃肠道癌症。模式正在改变吗?
Saudi Med J. 2000 Aug;21(8):730-4.
9
Bladder cancer in Saudi Arabia: a registry-based nationwide descriptive epidemiological and survival analysis.沙特阿拉伯膀胱癌:基于登记的全国描述性流行病学和生存分析。
Ann Saudi Med. 2022 Jan-Feb;42(1):17-28. doi: 10.5144/0256-4947.2022.17. Epub 2022 Feb 3.
10
The Incidence Rate of Esophageal Cancer in Saudi Arabia: An Observational and a Descriptive Epidemiological Analyses.沙特阿拉伯食管癌的发病率:观察性和描述性流行病学分析。
Front Public Health. 2022 Mar 23;10:818691. doi: 10.3389/fpubh.2022.818691. eCollection 2022.